|
Secondary prevention
Citations 61-70 of 568 total displayed.
|
Past content
(since Feb 1999):
|
- Articles
Sex Differences in Medical Care and Early Death After Acute Myocardial Infarction
- Hani Jneid, Gregg C. Fonarow, Christopher P. Cannon, Adrian F. Hernandez, Igor F. Palacios, Andrew O. Maree, Quinn Wells, Biykem Bozkurt, Kenneth A. LaBresh, Li Liang, Yuling Hong, L. Kristin Newby, Gerald Fletcher, Eric Peterson, Laura Wexler for the Get With the Guidelines Steering Committee and Investigators
Circulation published December 8, 2008, doi:10.1161/CIRCULATIONAHA.108.789800
[Abstract]
- Heart Failure
Heart Failure With Preserved and Reduced Left Ventricular Ejection Fraction in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
- Barry R. Davis, John B. Kostis, Lara M. Simpson, Henry R. Black, William C. Cushman, Paula T. Einhorn, Michael A. Farber, Charles E. Ford, Daniel Levy, Barry M. Massie, Shah Nawaz for the ALLHAT Collaborative Research Group
Circulation 2008;118:2259-2267; published online before print as doi:10.1161/CIRCULATIONAHA.107.762229
[Abstract]
[Full text]
- Articles
Cholesteryl Ester Transfer Protein Inhibition, High-Density Lipoprotein Raising, and Progression of Coronary Atherosclerosis. Insights From ILLUSTRATE (Investigation of Lipid Level Management Using Coronary Ultrasound to Assess Reduction of Atherosclerosis by CETP Inhibition and HDL Elevation)
- Stephen J. Nicholls, E. Murat Tuzcu, Danielle M. Brennan, Jean-Claude Tardif, and Steven E. Nissen
Circulation published November 24, 2008, doi:10.1161/CIRCULATIONAHA.108.790733
[Abstract]
- Articles
Heart Failure With Preserved and Reduced Left Ventricular Ejection Fraction in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
- Barry R. Davis, John B. Kostis, Lara M. Simpson, Henry R. Black, William C. Cushman, Paula T. Einhorn, Michael A. Farber, Charles E. Ford, Daniel Levy, Barry M. Massie, Shah Nawaz for the ALLHAT Collaborative Research Group
Circulation published November 10, 2008, doi:10.1161/CIRCULATIONAHA.107.762229
[Abstract]
- Cardiovascular Surgery
Impact of Statin Use on Outcomes After Coronary Artery Bypass Graft Surgery
- Alexander Kulik, M. Alan Brookhart, Raisa Levin, Marc Ruel, Daniel H. Solomon, and Niteesh K. Choudhry
Circulation 2008;118:1785-1792; published online before print as doi:10.1161/CIRCULATIONAHA.108.799445
[Abstract]
[Full text]
- Editorials
Hyperkalemia Associated With Inhibitors of the Renin-Angiotensin-Aldosterone System: Balancing Risk and Benefit
- Akshay Desai
Circulation 2008;118:1609-1611, doi:10.1161/CIRCULATIONAHA.108.807917
[Full text]
- Coronary Heart Disease
Greater Clinical Benefit of More Intensive Oral Antiplatelet Therapy With Prasugrel in Patients With Diabetes Mellitus in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel–Thrombolysis in Myocardial Infarction 38
- Stephen D. Wiviott, Eugene Braunwald, Dominick J. Angiolillo, Simha Meisel, Anthony J. Dalby, Freek W.A. Verheugt, Shaun G. Goodman, Ramon Corbalan, Drew A. Purdy, Sabina A. Murphy, Carolyn H. McCabe, Elliott M. Antman for the TRITON-TIMI 38 Investigators
Circulation 2008;118:1626-1636; published online before print as doi:10.1161/CIRCULATIONAHA.108.791061
[Abstract]
[Full text]
- Articles
Impact of Statin Use on Outcomes After Coronary Artery Bypass Graft Surgery
- Alexander Kulik, M. Alan Brookhart, Raisa Levin, Marc Ruel, Daniel H. Solomon, and Niteesh K. Choudhry
Circulation published October 13, 2008, doi:10.1161/CIRCULATIONAHA.108.799445
[Abstract]
- Surgery for Aortic Diseases
Tight Heart Rate Control Reduces Secondary Adverse Events in Patients With Type B Acute Aortic Dissection
- Kazuhisa Kodama, Kazuhiro Nishigami, Tomohiro Sakamoto, Tadashi Sawamura, Touitsu Hirayama, Hiroyasu Misumi, and Koichi Nakao
Circulation 2008;118:S167-170S, doi:10.1161/CIRCULATIONAHA.107.755801
[Abstract]
[Full text]
- Correspondence
Letter by Boriani et al Regarding Article, "Death Without Prior Appropriate Implantable Cardioverter-Defibrillator Therapy: A Competing Risk Study"
- Giuseppe Boriani, Igor Diemberger, and Francesco Grigioni
Circulation 2008;118:e515, doi:10.1161/CIRCULATIONAHA.108.798181
[Full text]
|
|
